logo
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

Malay Mail3 days ago
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited(01931.HK) - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA!In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited(01931.HK) took the lead in building the "NewCo+RWA" Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin "IVDDollar" (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation assets.On July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive stage.This strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion model.On July 18, 2025, local time, US President Trump signed the "Guidance and Establishment of the United States Stablecoin National Innovation Act" (hereinafter referred to as the "Genius Act") at the White House, establishing the legal status of stablecoins as "digital dollars". The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin market.The report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the "Hong Kong + US" dual hub compliance architecture layout.The strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the "Genius Act" for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong "Stablecoin Ordinance" to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the "Hong Kong Stock Stablecoin Concept Sector".The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology:1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets;2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's "1:1 redeemable" requirements;3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of "digital assets + traditional equity" to attract two-way inflows of traditional medical capital and crypto-native funds.The implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional investment.The Group's strategic advancement has always followed the three-dimensional path of "regulatory compliance-technological innovation-ecological synergy". In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license application.More importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and traceable.The Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of "NewCo+RWA+stablecoin".Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and investors.Hashtag: #IVDMedicalHoldingLimited
The issuer is solely responsible for the content of this announcement.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wall Street ends mixed, crude slides as trade deadline looms
Wall Street ends mixed, crude slides as trade deadline looms

Free Malaysia Today

time8 hours ago

  • Free Malaysia Today

Wall Street ends mixed, crude slides as trade deadline looms

The S&P 500 closed with nominal gains as underperforming tech shares dragged the Nasdaq into the red. (AP pic) NEW YORK : The Dow gained while the Nasdaq lost ground on Tuesday and crude settled lower as investors assessed a spate of mixed earnings and signs that President Donald Trump's protracted trade war is hitting corporate profit margins, even as Trump's dealmaking deadline approached. The S&P 500 closed with nominal gains as underperforming tech shares dragged the Nasdaq into the red. Gold extended its gains in opposition to the softening dollar, and US Treasury yields eased for the third-straight session. '(Investors are) looking for additional catalysts and you're seeing some cautious comments coming out of companies,' said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut. 'They're hearing mixed guidance when it comes to all this uncertainty revolving around tariffs and the direction things are heading.' Second-quarter earnings season has hit full stride, with nearly one-fifth of the companies in the S&P 500 having reported. Of those, 79% have beaten analyst expectations, according to LSEG data. Analysts expect year-on-year S&P 500 earnings growth of 7%, on aggregate, a sizable improvement over the 5.8% growth predicted as of July 1, per LSEG. Still, the effects of the trade war have begun seeping into corporate results. General Motors' second-quarter core profit slid 32% as steep tariff costs took a US$1.1-billion bite from its bottom line. Prospects of a US-European Union trade deal appeared to be fading as Washington's Aug 1 deadline loomed, prompting EU members to ramp up possible 'anti-coercion' retaliatory measures. US treasury secretary Scott Bessent said on Tuesday he would meet with his Chinese counterpart to discuss delaying the Aug 12 trade talks deadline with China again, as the world's two largest economies wrestle with the flow of technology and rare earth materials. 'These are pretty classic negotiations; nothing ever happens until it has to happen,' says Chuck Carlson, CEO at Horizon Investment Services in Hammond, Indiana. 'Nothing gets done until the deadline, then either the deadline gets extended or there's some resolution that comes out of nowhere.' 'The flip side of this is Trump's going to have to follow through eventually,' Carlson added. 'Otherwise, he's going to be the boy that cried wolf, and his negotiating power is going to be sapped because people will believe he's never going to follow through.' The Dow Jones Industrial Average rose 179.12 points, or 0.40%, to 44,502.19, the S&P 500 rose 3.99 points, or 0.06%, to 6,309.59 and the Nasdaq Composite fell 81.49 points, or 0.39%, to 20,892.69. European shares ended lower, weighed down by disappointing earnings and looming anxieties over the lack of progress in US trade negotiations. MSCI's gauge of stocks across the globe rose 0.68 points, or 0.07%, to 930.31. The pan-European STOXX 600 index fell 0.41%, while Europe's broad FTSEurofirst 300 index fell 8.50 points, or 0.39% Emerging market stocks fell 3.93 points, or 0.31%, to 1,249.53. MSCI's broadest index of Asia-Pacific shares outside Japan closed lower by 0.17%, to 657.56, while Japan's Nikkei fell 44.19 points, or 0.11%, to 39,774.92. The dollar continued to edge lower amid a subdued currency market as investors awaited any sign of progress in trade talks ahead of the August 1 deadline. The dollar index, which measures the greenback against a basket of currencies including the yen and the euro, fell 0.5% to 97.36, with the euro up 0.49% at US$1.1752. Against the Japanese yen, the dollar weakened 0.56% to 146.56. Bitcoin gained 1.98% to US$119,320.90. Ethereum declined 2.41% to US$3,668.31. US Treasury yields appeared set to notch a third-straight day of declines as the market took a breather on the heels of Monday's rally. The yield on benchmark US 10-year notes fell 2.8 basis points to 4.342%, from 4.37% late on Monday. The 30-year bond yield fell 2.6 basis points to 4.9111% from 4.937% late on Monday. The 2-year note yield, which typically moves in step with interest rate expectations for the Federal Reserve, fell 1.9 basis points to 3.833%, from 3.852% late on Monday. Oil prices weakened on growing worries over softening demand as the Aug 1 tariff deadline drew closer. US crude slid 1.47% to settle at US$66.21 per barrel, while Brent settled at US$68.59 per barrel, down 0.9%. Gold prices surpassed a five-week high, extending their gains on the softening dollar and weaker US bond yields. Spot gold rose 1.07% to US$3,431.87 an ounce. US gold futures rose 1.15% to US$3,441.00 an ounce.

Goldman, BNY launching tokens tied to money market funds
Goldman, BNY launching tokens tied to money market funds

Free Malaysia Today

time8 hours ago

  • Free Malaysia Today

Goldman, BNY launching tokens tied to money market funds

The crypto industry has rallied in recent months amid surging optimism. (EPA Images pic) NEW YORK : Goldman Sachs and BNY have joined hands to launch digital tokens that mirror shares of money market funds, deepening Wall Street's push to bring blockchain technology into traditional finance. Investors can now buy and sell money market fund shares on BNY's LiquidityDirect platform, with a digital record of those shares created on Goldman's blockchain system, the two financial giants said today. The move marks an early step toward modernising the infrastructure that underpins most of the financial ecosystem. If adopted broadly, it could make it easier and faster for institutional investors to use these assets as collateral and reduce trade settlement times. BlackRock, BNY Investments Dreyfus, Federated Hermes, Fidelity Investments and Goldman Sachs Asset Management are among the companies participating in the initial rollout. Though a subject of debate, tokenisation's potential to drastically reshape the investing landscape has drawn strong interest. In January, Apollo teamed up with Securitize to launch a feeder fund that would channel capital from crypto-native investors into its global credit fund. The moves coincide with and gained fresh momentum after the Genius Act passed earlier this month.

China, Hong Kong stocks power ahead as eased trade tensions fuel rally
China, Hong Kong stocks power ahead as eased trade tensions fuel rally

Free Malaysia Today

time9 hours ago

  • Free Malaysia Today

China, Hong Kong stocks power ahead as eased trade tensions fuel rally

Hong Kong's benchmark Hang Seng jumped more than 1% to hit its highest level in almost four years. (EPA Images pic) SHANGHAI : China and Hong Kong stocks powered ahead today as signs of eased Sino-US trade tensions added fuel to a rally driven by Beijing's campaign against intense price wars and a trillion-yuan hydropower dam project in Tibet. China's blue-chip CSI300 Index climbed 0.7% by the midday break, reaching an eight-month peak and on track for a fifth straight session of gains. The Shanghai Composite Index rose 0.8%. Hong Kong's benchmark Hang Seng jumped more than 1% to hit its highest level in almost four years. In a sign the rally likely has legs, daily turnover in China stocks has expanded to near five-month highs, while margin financing – money borrowed to buy stocks – has hit a level not seen in nearly four months, signalling revived 'animal spirits'. 'External and internal headwinds have subsided faster than expected,' Huatai Securities said in a note to clients, adding that 'in the latest round of tariff talks with the US, China has strengthened its hand'. 'China's economy benefits from the government's stepped-up campaign against 'involutionary competition' and positive real estate policies,' Huatai added. In a sign of reduced tensions, US treasury secretary Scott Bessent said yesterday that US and Chinese officials will meet in Stockholm next week to discuss an extension to the deadline for negotiating a trade deal. 'I think trade is in a very good place with China,' Bessent said. Chinese tech stocks, which are sensitive to Sino-US relations, jumped today. China's tech-focused STAR50 Index gained 1%, while Hong Kong's Hang Seng Tech Index jumped nearly 2%. China-listed chemicals and steel continued to rise amid bets producers in these sectors will benefit from Beijing's expected industrial capacity cuts. Building materials and construction engineering stocks also powered ahead, as China's massive hydropower dam project brightened the sectors' prospects. 'The construction of a hydropower dam in Tibet has greatly lifted investor sentiment as well as earnings forecasts of related industries,' Guotai Haitong Securities said in a report.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store